These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11325884)

  • 21. Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD).
    Michils G; Tejpar S; Fryns JP; Legius E; Van Cutsem E; Cassiman JJ; Matthijs G
    Eur J Hum Genet; 2002 Sep; 10(9):505-10. PubMed ID: 12173026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.
    Caleffi M; Teague MW; Jensen RA; Vnencak-Jones CL; Dupont WD; Parl FF
    Cancer; 1994 Apr; 73(8):2147-56. PubMed ID: 8156519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of p53 mutations in bilateral breast carcinoma.
    Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
    Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.
    Allred DC; Clark GM; Elledge R; Fuqua SA; Brown RW; Chamness GC; Osborne CK; McGuire WL
    J Natl Cancer Inst; 1993 Feb; 85(3):200-6. PubMed ID: 8423624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic mutation detection. Phosphate ions increase incision efficiency of endonuclease VII at a variety of damage sites in DNA.
    Golz S; Greger B; Kemper B
    Mutat Res; 1998 May; 382(3-4):85-92. PubMed ID: 9691988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations.
    Moore L; Godfrey T; Eng C; Smith A; Ho R; Waldman FM
    Biotechniques; 2000 May; 28(5):986-92. PubMed ID: 10818706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Moll UM; Riou G; Levine AJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7262-6. PubMed ID: 1353891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of p53 gene mutations in fine-needle aspiration biopsied breast cancer specimens: correlations with nuclear p53 accumulations and tumor DNA aneuploidy patterns.
    Sato T; Yuyama Y; Watabe K; Okazaki A; Toda K; Okazaki M; Hirata K
    Cancer Lett; 1997 May; 115(1):47-55. PubMed ID: 9097978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homogeneous amplification and mutation scanning of the p53 gene using fluorescent melting curves.
    Millward H; Samowitz W; Wittwer CT; Bernard PS
    Clin Chem; 2002 Aug; 48(8):1321-8. PubMed ID: 12142390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 Mutation analysis in breast tumors by a DNA microarray method.
    Tennis M; Krishnan S; Bonner M; Ambrosone CB; Vena JE; Moysich K; Swede H; McCann S; Hall P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):80-5. PubMed ID: 16434591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
    Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
    Shao ZM; Wu J; Shen ZZ; Nguyen M
    Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
    Meng L; Lin L; Fresno M; Morales AR; Nadji M
    Int J Oncol; 1999 Sep; 15(3):555-8. PubMed ID: 10427139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors.
    Levy CB; Stumbo AC; Ano Bom AP; Portari EA; Cordeiro Y; Silva JL; De Moura-Gallo CV
    Int J Biochem Cell Biol; 2011 Jan; 43(1):60-4. PubMed ID: 21056685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing.
    Chakravarty G; Redkar A; Mittra I
    Br J Cancer; 1996 Oct; 74(8):1181-7. PubMed ID: 8883402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.